-
Marine n-3 PUFAs act as pleiotropic agents on the cardiovascular system with a diverse range of effects most of which are beneficial for patients with known cardiovascular disease and possibly, they may even have beneficial effects with regard to the primary prevention of cardiovascular disease.
-
Clinicians should consider prescribing levothyroxine at bedtime since this study demonstrates significantly improved thyroid hormone levels compared to morning intake.
-
It seems reasonable to assume that atorva-statin has some anti-ischemic properties, based on the strong correlation between subjective angina reduction and reduction in objective ischemia demonstrated on AECG monitoring. However, there was no incremental benefit to the combination of atorvastatin and amlodipine.
-
Although most older women have stable patterns of alcohol use over time, they still need to be periodically questioned about alcohol use since some will increase their intake substantially after age 50, and may develop new risks for alcohol-related problems.
-
Simply increasing the number of steps taken daily reduces obesity and improves insulin sensitivity in middle-aged adults.
-
A new chemotherapeutic agent has been approved for the treatment of metastatic breast cancer previously treated with other chemotherapeutic agents.
-
The most recent ada/easd algorithm for management of type 2 diabetes (DM2) indicates basal insulin as an appropriate next step if glycemic goals are not attained with metformin and lifestyle interventions.
-
Sleep-deprived individuals appear less healthy, tired, and less attractive to untrained observers than when they are rested.
-
The FDA has approved a second dipeptidyl peptidase-4 (DPP-4) inhibitor and metformin combination. This follows the approval of sitagliptin/metformin in 2007.
-
The surface ECG shows the net result of electrical forces that are operative. This concept is important to remember when potential "competing conditions" are operative.
